Acadia Pharmaceuticals | ACAD - 流动资产

金融业

USD 21.24

USD 1.79B

现金及等价物

USD 976.45M

USD 35.09M

USD 1.27B

USD 332.22M

USD 73.85M

USD 71.72M

USD 40.99M

653

EPS每股收益

USD 0.31

股本和储备

USD 1.39B

USD 307.2M

债务利息支出

USD 0

USD 7.99M

USD 0

USD 3.57B

USD 53.52M

USD 270.57M

USD 71.72M

普通股股本

USD 172.31M

9.52

USD 80.44M

USD 342M

销售和管理费用

USD 146.88M

USD 40.36M

贸易债权人

USD 16.33M

应收帐款人

USD 178.32M

	流动资产	更改		日
Acadia Pharmaceuticals	USD 1.27B		43.88M	2026-09
ALKERMES	USD 1.58B		57.83M	2026-09
Alnylam Pharmaceuticals	USD 5.11B		492.49M	2026-09
Biogen	USD 7.58B		278.7M	2026-09
BioMarin Pharmaceutical	USD 3.92B		50.99M	2026-09
Bristol-Myers Squibb	USD 29.77B		1.19B	2026-09
Cara Therapeutics	USD 25.33M		6.21M	2026-03
Corcept Therapeutics	USD 533.87M		94.2M	2026-09
Cytokinetics	USD 1.19B		21.34M	2026-09
Eisai	JPY 883.01B		121.38B	2026-06
Eli Lilly	USD 65.26B		591M	2026-09
Incyte	USD 5.52B		505.2M	2026-09
J&J	USD 56.35B		3.42B	2026-09
Moderna	USD 5.82B		45M	2026-06
Neurocrine Biosciences	USD 2.01B		370.7M	2026-09
Pfizer	USD 45.01B		3.65B	2026-09
Prothena	USD 273.86M		18.15M	2026-09
PTC Therapeutics	USD 2.54B		79.58M	2026-09
Sarepta Therapeutics	USD 2.22B		86.05M	2026-06
Ultragenyx Pharmaceutical	USD 544M		62M	2026-09
Vanda Pharmaceuticals	USD 347.26M		20.23M	2025-12
Vertex Pharmaceuticals	USD 11.69B		857.4M	2026-09